Tri Locum Partners LP Cyclacel Pharmaceuticals, Inc. Transaction History

Tri Locum Partners LP

  • $387 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.04 - $8.03 $3.16 Million - $4.2 Million
-522,943 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$8.02 - $11.0 $1.68 Million - $2.31 Million
209,612 Added 66.9%
522,943 $2.76 Million
Q2 2021

Aug 16, 2021
BUY
$7.59 - $10.48 $151,132 - $208,677
19,912 Added 6.79%
313,331 $1.86 Million
Q1 2021

May 17, 2021
BUY
$6.86 - $9.24 $2.01 Million - $2.71 Million
293,419 New
293,419 $2.09 Million

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $12.5M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email